Heart failure: a growing public health problem

Journal of Internal Medicine

Volumn 237, Issue 2, 1995, Pages 135-141

  ERIKSSON, H ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

epidemiology; heart failure; socioeconomics; treatment

Indexed keywords

CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; RAMIPRIL;

HEART FAILURE; HUMAN; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW; RISK FACTOR; SOCIOECONOMICS; SWEDEN;

EID: 0028962623     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.1995.tb01153.x     Document Type: Review

References (37)

1. Epidemiology and prognosis of heart failure
2. Prolonging life in patients with congestive heart failure: the next frontier
3. Changes in hypertension treatment and in congestive heart failure mortality in the United States
4. Incidence of heart failure in eastern Finland: a population‐based surveillance study
5. Risk factors for heart failure in the general population: The Study of Men Born in 1913
6. Chronic heart failure. Socioeconomic relevance in the Federal Republic of Germany
7. Epidemiology of heart failure
8. Prevalence and mortality rate of congestive heart failure in the United States
9. The natural history of congestive heart failure: The Framingham Study
10. Early heart failure in the population. The Study of Men Born in 1913
11. Prevalence of heart failure in three general practices in north west London
12. Survival in congestive heart failure: have we made a difference
13. Survival after the onset of congestive heart failure in Framingham Heart Study subjects
14. Epidemiological aspects of heart failure
15. Effect of enalapril on mycocardial infarction and unstable angina in patients with low ejection fractions
16. Global perspective on health service financing
17. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure
18. Trends in hospitalization rates for heart failure in the United States. 1973–1986. Evidence for increasing population prevalence
19. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions
20. Epidemiologic aspects of heart failure
21. Quality of life in early heart failure. The Study of Men Born in 1913
22. Selection of patients for cardiac transplantation
23. Studies of Left Ventricular Dysfunction (SOLVD) registry: rationale, design, methods and description of baseline characteristics
24. Chronic congestive heart failure in coronary artery disease: clinical criteria
25. Epidemiologic patterns, clinical evaluation, and longterm prognosis in chronic congestive heart failure
26. Effects of enalapril on mortality in severe heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)
27. A comparison of enalapril with hydralazine‐isosorbide dinitrate in the treatment of chronic congestive heart failure
28. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the Survival and Ventricular Enlargement Trial
29. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure
30. Difference in mortality between patients treated with captopril or enalapril in the xamoterol in severe heart failure study
31. Clinical and neurohumoral response of patients with severe congestive heart failure treated with two different captopril dosages
32. ACE inhibitors—a cornerstone of the treatment of heart failure (Editorial)
33. Treatment of chronic heart failure